| Year |
Citation |
Score |
| 2013 |
Wolford CC, McConoughey SJ, Jalgaonkar SP, Leon M, Merchant AS, Dominick JL, Yin X, Chang Y, Zmuda EJ, O'Toole SA, Millar EK, Roller SL, Shapiro CL, Ostrowski MC, Sutherland RL, et al. Transcription factor ATF3 links host adaptive response to breast cancer metastasis. The Journal of Clinical Investigation. 123: 2893-906. PMID 23921126 DOI: 10.1172/Jci64410 |
0.304 |
|
| 2011 |
Wolford CC, McConoughey S, Yin X, Merchant A, Leon ME, O'Toole S, Sutherland R, Ostrowski M, Hai T. Abstract 2843: Tumor macrophages utilize ATF3 to promote breast cancer metastasis Cancer Research. 71: 2843-2843. DOI: 10.1158/1538-7445.Am2011-2843 |
0.3 |
|
| 2010 |
Yin X, Wolford CC, Chang YS, McConoughey SJ, Ramsey SA, Aderem A, Hai T. ATF3, an adaptive-response gene, enhances TGF{beta} signaling and cancer-initiating cell features in breast cancer cells. Journal of Cell Science. 123: 3558-65. PMID 20930144 DOI: 10.1242/Jcs.064915 |
0.307 |
|
| 2010 |
McConoughey SJ, Basso M, Niatsetskaya ZV, Sleiman SF, Smirnova NA, Langley BC, Mahishi L, Cooper AJ, Antonyak MA, Cerione RA, Li B, Starkov A, Chaturvedi RK, Beal MF, Coppola G, et al. Inhibition of transglutaminase 2 mitigates transcriptional dysregulation in models of Huntington disease. Embo Molecular Medicine. 2: 349-70. PMID 20665636 DOI: 10.1002/Emmm.201000084 |
0.493 |
|
| 2010 |
Niatsetskaya Z, Basso M, Speer RE, McConoughey SJ, Coppola G, Ma TC, Ratan RR. HIF prolyl hydroxylase inhibitors prevent neuronal death induced by mitochondrial toxins: therapeutic implications for Huntington's disease and Alzheimer's disease. Antioxidants & Redox Signaling. 12: 435-43. PMID 19659431 DOI: 10.1089/Ars.2009.2800 |
0.509 |
|
| 2009 |
McConoughey SJ, Niatsetskaya ZV, Pasternack R, Hils M, Ratan RR, Cooper AJ. A nonradioactive dot blot assay for transglutaminase activity. Analytical Biochemistry. 390: 91-3. PMID 19306836 DOI: 10.1016/J.Ab.2009.03.022 |
0.462 |
|
| 2008 |
Ratan RR, Siddiq A, Aminova L, Langley B, McConoughey S, Karpisheva K, Lee HH, Carmichael T, Kornblum H, Coppola G, Geschwind DH, Hoke A, Smirnova N, Rink C, Roy S, et al. Small molecule activation of adaptive gene expression: tilorone or its analogs are novel potent activators of hypoxia inducible factor-1 that provide prophylaxis against stroke and spinal cord injury. Annals of the New York Academy of Sciences. 1147: 383-94. PMID 19076458 DOI: 10.1196/Annals.1427.033 |
0.492 |
|
| 2007 |
Ratan RR, Siddiq A, Smirnova N, Karpisheva K, Haskew-Layton R, McConoughey S, Langley B, Estevez A, Huerta PT, Volpe B, Roy S, Sen CK, Gazaryan I, Cho S, Fink M, et al. Harnessing hypoxic adaptation to prevent, treat, and repair stroke. Journal of Molecular Medicine (Berlin, Germany). 85: 1331-8. PMID 18043901 DOI: 10.1007/S00109-007-0283-1 |
0.479 |
|
| 2005 |
Krasnikov BF, Kim SY, McConoughey SJ, Ryu H, Xu H, Stavrovskaya I, Iismaa SE, Mearns BM, Ratan RR, Blass JP, Gibson GE, Cooper AJ. Transglutaminase activity is present in highly purified nonsynaptosomal mouse brain and liver mitochondria. Biochemistry. 44: 7830-43. PMID 15909997 DOI: 10.1021/Bi0500877 |
0.495 |
|
| Show low-probability matches. |